Coffin-Siris syndrome 1 is a rare genetic condition that affects development of many body systems. People with Coffin-Siris syndrome 1 often have developmental delay, learning differences, and delayed speech. Many also have feeding issues in infancy, low muscle tone, and distinctive features that doctors can see, such as absent or underdeveloped fingernails or toenails on the fifth fingers or toes. Symptoms start in infancy or early childhood and usually last lifelong, but not everyone will have the same experience. Treatment focuses on supportive therapies, such as speech, physical, and occupational therapy, and most people with Coffin-Siris syndrome 1 can live into adulthood with appropriate care.
Overview
Coffin-siris syndrome 1Symptoms
People with Coffin-Siris syndrome 1 often have developmental and speech delays, learning differences, and low muscle tone. Common signs include small or missing fifth nails, short fifth fingers, coarse facial features, hair differences, feeding problems, and poor growth.
Outlook and prognosis
Most children with Coffin‑Siris syndrome 1 grow and learn at their own pace, often needing ongoing therapies and school supports. Health issues like feeding difficulties, infections, or breathing problems are most common early and can improve with care. With coordinated specialists and family support, many gain new skills and quality of life over time.
Causes and risk factors
Coffin-Siris syndrome 1 results from a change, usually new, in the ARID1B gene with autosomal dominant inheritance. Family history increases risk; rare parental germline mosaicism can recur. Environment and lifestyle don’t cause it but may affect complications.
Genetic influences
Genetics are central to Coffin-Siris syndrome 1. Most cases result from a single harmful change in the ARID1B gene, often occurring for the first time in a child. Rarely, it can be inherited, and genetic testing confirms the diagnosis and guides family planning.
Diagnosis
Doctors suspect Coffin-Siris syndrome 1 from recognizable clinical features and developmental history. Genetic diagnosis of Coffin-Siris syndrome 1 is confirmed by testing for ARID1B or related gene changes; imaging and specialist evaluations help document associated features.
Treatment and drugs
Care for Coffin‑Siris syndrome 1 focuses on supportive therapies matched to each person’s needs. Many benefit from early developmental therapies, speech and feeding support, hearing and vision care, and management of breathing, heart, or gastrointestinal issues. Teams may include genetics, neurology, cardiology, gastroenterology, orthopedics, and behavioral health, with individualized plans that adapt over time.
Symptoms
People with Coffin-Siris syndrome 1 often have a mix of developmental and physical traits that appear in infancy or early childhood. Early features of Coffin-Siris syndrome 1 can include feeding difficulties, slow growth, and differences in the pinky fingers or toenails. Many also have learning and speech delays that become clearer as school demands increase. Features vary from person to person and can change over time.
Milestones like sitting, crawling, and walking may come later than usual. In Coffin-Siris syndrome 1, progress often continues steadily with therapies.
First words and longer phrases tend to be delayed. Speech therapy, sign support, or communication devices can help children express themselves.
Babies may have trouble latching, sucking, or coordinating swallowing. This can lead to slow weight gain and may require thickened feeds or temporary tube support.
Some children grow more slowly and may be shorter as they get older. Doctors track patterns over time in centimeters and inches to guide care.
How people usually first notice Coffin-siris syndrome 1?
Many families first notice signs of Coffin–Siris syndrome 1 in infancy when a baby has feeding difficulties, poor weight gain, or seems delayed in hitting early milestones like sitting or babbling. Doctors are often alerted by distinctive physical features, especially underdeveloped or absent nails and the last joints of the fifth fingers or toes, along with coarse facial features that become more apparent over time. For many, the first signs of Coffin–Siris syndrome 1 emerge during newborn checkups or early childhood evaluations for developmental delay and low muscle tone, prompting genetic testing to confirm the diagnosis.
Types of Coffin-siris syndrome 1
Coffin-Siris syndrome 1 is a genetic condition with recognized clinical variants linked to different genes in the BAF (SWI/SNF) chromatin-remodeling complex. These variants can look broadly similar—developmental delays, feeding issues in infancy, distinctive facial and finger/toe features—but severity and added health concerns may differ by gene. Clinicians often describe them in these categories: ARID1B-related (historically “type 1”) and other BAF-gene–related subtypes, which helps explain why symptoms vary from mild to more complex. Not everyone will experience every type of symptom, and understanding the types of Coffin-Siris syndrome can clarify why two children with the same diagnosis have different needs.
ARID1B-related (type 1)
This is the most common variant and often presents with global developmental delay, speech delay, and fifth finger or toe underdevelopment. Many have milder medical complications compared with other genes, though learning support is commonly needed. Early symptoms of Coffin-Siris syndrome type 1 may include feeding difficulties and slower motor milestones.
ARID1A-related
Features can overlap with ARID1B but may include more pronounced growth differences, feeding challenges, or organ involvement. Some have a higher chance of congenital anomalies, so doctors may recommend broader screening. Speech and motor delays are typical, with variable intensity.
SMARCB1-related
This subtype can bring similar developmental concerns plus distinct facial features and skeletal differences. Some individuals may have a higher risk for specific medical complications that require focused monitoring. Support needs often span speech, motor, and educational services.
SMARCA4-related
Children may show developmental and speech delays along with more noticeable hypotonia (low muscle tone) and feeding issues in infancy. Certain congenital differences can occur, so early cardiac, hearing, and vision checks are often advised. Symptom severity can range from mild to more complex.
SMARCE1-related
Developmental delays are common, with overlap in facial and digit features typical of Coffin-Siris syndrome. Some may have additional neurologic or structural findings that guide testing and follow-up. Educational and therapy supports are tailored to the child’s strengths.
DPF2-related
This less common variant shares the core Coffin-Siris pattern but may include added behavioral or neurologic features. Medical teams often individualize surveillance based on the child’s profile. The balance of symptoms can shift over time.
Other BAF-gene variants
Changes in genes like SOX11 or others within the BAF pathway can lead to a Coffin-Siris–like presentation. These variants are rarer, and symptom patterns can be more variable, so personalized care plans are key. Discussing types of Coffin-Siris syndrome with a geneticist can help set expectations for monitoring and support.
What genetics can tell you about symptoms
Some people with Coffin‑Siris syndrome 1 have ARID1B gene changes that can lead to developmental delays, speech challenges, feeding difficulties, and distinctive facial or fifth‑finger/toe features. These variations can also relate to low muscle tone, frequent infections, and learning differences.
Causes and risk factors
Coffin-siris syndrome 1 is usually caused by a new change in the ARID1B gene.
Risk is based on the gene change, not early symptoms of Coffin-siris syndrome 1.
Most cases are not inherited, but if a parent has the same change, each child has a 50% chance of inheriting it.
Doctors distinguish between risk factors you can change and those you can’t.
Family history raises risk, while lifestyle or environment do not cause the condition but may influence how features vary.
Environmental and biological risk factors
For Coffin-Siris syndrome 1, the overall chance in any pregnancy is very low, and most cases arise unexpectedly. Doctors often group risks into internal (biological) and external (environmental). Below are the environmental and biological risk factors for Coffin-Siris syndrome 1 that are currently known, along with areas where no clear links have been found.
Older fathers have a higher rate of new changes in sperm that can lead to conditions present from birth. This slightly increases the chance of a first‑time change causing Coffin-Siris syndrome 1. The absolute risk remains small.
No specific environmental exposures have been shown to increase the risk of Coffin-Siris syndrome 1. Research to date has not identified air pollution, radiation, or chemicals as proven triggers. Ongoing studies continue to monitor potential links.
Genetic risk factors
Most cases of Coffin-Siris syndrome 1 trace back to changes in a single gene called ARID1B. People with the same risk factor can have very different experiences. These changes usually happen for the first time in a child (de novo), but they can also be inherited in an autosomal dominant pattern. Genetic testing is often suggested when early symptoms of Coffin-Siris syndrome 1 raise concern, to confirm the cause and guide family planning.
ARID1B gene changes: Pathogenic changes in ARID1B disrupt a protein that helps control how other genes turn on and off. This is the primary genetic cause of Coffin-Siris syndrome 1. Most are loss-of-function changes that reduce the amount of working protein.
Chromosome 6q25 loss: Some people have a small missing piece of chromosome 6 that includes ARID1B. This microdeletion lowers ARID1B levels and leads to Coffin-Siris syndrome 1. It can be the only finding or part of a larger deletion.
Usually de novo: In most families, the ARID1B change happens randomly in the egg or sperm and is not present in either parent. When truly de novo, the chance of it happening again in another child is low. Parental testing helps estimate recurrence risk.
Autosomal dominant pattern: If a parent carries a disease-causing ARID1B change, each child has a 50% chance of inheriting it. Features can be milder or more obvious from one person to the next. Family history may be subtle if a parent is only mildly affected.
Parental mosaicism: Occasionally, a parent has the ARID1B change in some egg or sperm cells but not in their blood. This hidden mosaicism can slightly raise the chance of another affected child even when parental blood tests are negative. Genetic counseling can explain these odds.
Type of variant: Truncating or loss-of-function changes are the most common cause and usually clearly disease-causing. Some missense changes need careful review to confirm they affect gene function. Lab classification guides whether a finding explains Coffin-Siris syndrome 1.
Variable expressivity: The same ARID1B change can lead to different degrees of learning, growth, and physical features among relatives. Severity can range from mild to more pronounced. This variation can make family patterns hard to recognize.
BAF complex role: ARID1B is part of a gene-regulating complex that helps cells develop in the right way. Disruption of this complex during early development underlies the condition. This helps explain why multiple body systems can be involved in Coffin-Siris syndrome 1.
Lifestyle risk factors
Coffin-Siris syndrome 1 is not caused by lifestyle, but daily habits can shape how symptoms evolve, skills develop, and complications are prevented. This overview explains how lifestyle affects Coffin-siris syndrome 1 and highlights practical areas families can influence. The elements below outline lifestyle risk factors for Coffin-siris syndrome 1 that may worsen or improve outcomes depending on choices.
Energy-dense, balanced meals and safe feeding techniques support growth and reduce fatigue in people with Coffin-Siris syndrome 1. Poor intake can worsen low muscle tone and delay motor and cognitive progress.
Regular, tailored play and physiotherapy can improve strength, balance, and breathing efficiency in Coffin-Siris syndrome 1. Inactivity raises risks of stiffness, falls, and constipation that hinder participation.
Consistent practice of occupational, physical, and speech goals at home reinforces clinic gains in Coffin-Siris syndrome 1. Inconsistent carryover slows skill acquisition and functional independence.
Daily modeling and use of augmentative or alternative communication can expand language and social engagement in Coffin-Siris syndrome 1. Limited practice reduces communication success and increases frustration-related behaviors.
Risk prevention
Coffin-Siris syndrome 1 is a genetic condition present from birth, so it can’t be fully prevented. Prevention focuses on lowering the chance of complications and protecting long‑term health with timely care and monitoring. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. Genetic counseling before pregnancy can help families understand options and plan ahead.
Meet with a genetics professional to review family history and chances of passing on Coffin-Siris syndrome 1. They can discuss reproductive options, including IVF with embryo testing if a family variant is known.
If a known family variant exists or scans raise questions, ask about diagnostic tests during pregnancy. Options like chorionic villus sampling or amniocentesis can check for Coffin-Siris syndrome 1 before birth.
Regular check-ups in infancy can help spot early symptoms of Coffin-Siris syndrome 1, such as feeding trouble or slower motor milestones. An early care plan often prevents avoidable complications.
Keep all recommended childhood and adult vaccines up to date to lower the risk of serious infections. Ask about influenza and other seasonal vaccines based on local guidance.
Transmission
Coffin-Siris syndrome 1 is not contagious—you can’t catch it or spread it. It results from a change in a single gene, and in most families this is a new change that starts in the egg or sperm. The condition is autosomal dominant, which means if a parent has Coffin-Siris syndrome 1, each pregnancy has a 50% chance of inheriting the gene change, though the signs can range from mild to more noticeable. A genetics visit can explain how Coffin-Siris syndrome 1 is inherited and discuss the genetic transmission of Coffin-Siris syndrome 1 in your family.
When to test your genes
Coffin–Siris syndrome 1 is genetic, so testing is most useful when there are suggestive features (developmental delay, absent fifth-fingernail/toenail, distinctive facial features) or a family history. Genetic confirmation guides care plans and surveillance. Consider testing before major interventions or pregnancy to inform management and reproductive options.
Diagnosis
Coffin-siris syndrome 1 is typically recognized by a pattern of developmental delays, feeding challenges in infancy, and small or missing fingernails or toenails, most often on the fifth digits. Doctors usually begin with a careful physical exam and developmental review, then consider tests to confirm the cause. The genetic diagnosis of Coffin-siris syndrome 1 most often involves finding a change in the ARID1B gene.
Providers look for features such as small or absent fifth fingernails or toenails, distinctive facial traits, and low muscle tone. These visible clues raise suspicion for Coffin-siris syndrome 1. They also help decide which tests to order next.
A detailed look at motor, speech, and learning milestones helps define the pattern of delay. This information can separate Coffin-siris syndrome 1 from other causes of developmental differences.
Your team will ask about similar features or learning differences in relatives and any pregnancy or birth concerns. Most cases arise as a new genetic change, so parents typically do not have the condition.
A lab can check the ARID1B gene for spelling changes or small missing or extra sections. Finding a disease-causing change confirms Coffin-siris syndrome 1.
Stages of Coffin-siris syndrome 1
Coffin-siris syndrome 1 does not have defined progression stages. It’s a lifelong condition that begins before birth, and features can vary widely from person to person and shift with growth and therapy rather than moving through set phases. Early symptoms of Coffin-siris syndrome 1 may include feeding challenges, slower motor milestones, or small nails on the fifth fingers or toes, and doctors track development over time. Genetic testing may be offered to clarify certain risks, alongside a physical exam, developmental assessments, and eye, hearing, or heart checks as needed.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Coffin-Siris syndrome 1, day-to-day life centers on supporting developmental skills, speech, and motor coordination. Early care can make a real difference in how children learn, communicate, and move, and some families see steady gains with therapies, tailored education, and accessible tools. Many people ask, “What does this mean for my future?”, and the answer usually depends on how severe the features are, whether feeding or breathing issues are present, and how quickly supports are put in place.
Prognosis refers to how a condition tends to change or stabilize over time. Many living with Coffin-Siris syndrome 1 have a normal life span, especially when medical issues like infections, seizures, or heart differences are well managed. Serious complications are possible but less common; early symptoms of Coffin-Siris syndrome 1 that raise concern include feeding trouble, recurrent chest infections, or seizures, which should prompt close follow-up. Some people experience fewer medical complications over time as growth improves, while others notice ongoing needs for therapies, assistive communication, or help with daily routines.
Everyone’s journey looks a little different. With ongoing care, many people maintain good health and make meaningful functional progress, though independent living may not be realistic for some. Talk with your doctor about what your personal outlook might look like, including monitoring plans and ways to prevent complications. Genetic testing can sometimes provide more insight into prognosis, since different gene changes within the Coffin-Siris spectrum can track with milder or more complex needs.
Long-term effects
For most, the long-term outlook for Coffin-Siris syndrome 1 depends on the mix of developmental, medical, and behavioral features present. Long-term effects vary widely, and may change across childhood, adolescence, and adulthood. Many reach adulthood, especially when no major heart, kidney, or airway problems are present. Even within Coffin-Siris syndrome 1, abilities and health needs can differ over time.
Learning differences are common, ranging from mild to more pronounced challenges. Many continue to gain new skills over time.
Speech often develops late and may remain limited compared with understanding. Some rely more on gestures or simplified language.
Low muscle tone and coordination differences can persist. Walking and balance usually improve, but fine-motor tasks may stay harder.
Short stature and a smaller head size can continue into adulthood. Weight gain may be slow in early years and stabilize later.
How is it to live with Coffin-siris syndrome 1?
Life with Coffin-Siris syndrome 1 can be a mix of steady routines and extra support, shaped by developmental delays, low muscle tone, and differences in speech and learning. Daily life often involves therapies—physical, occupational, and speech—along with special education and adaptive tools to build independence, while medical visits track growth, feeding, breathing, and infections. Families and caregivers may spend more time coordinating care and advocating at school or in the community, yet many also find strong networks, clear progress with consistent practice, and joy in celebrating milestones reached at each person’s pace. Friends, classmates, and relatives can make a real difference by offering patience, accessible activities, and communication that meets the person where they are.
Treatment and drugs
Treatment for Coffin-Siris syndrome 1 focuses on supportive care that targets each person’s needs rather than a single cure. Supportive care can make a real difference in how you feel day to day. Care plans often include early intervention therapies such as physical, occupational, and speech therapy to support movement, feeding, communication, and learning, plus educational supports and behavioral strategies as children grow. Doctors sometimes recommend a combination of lifestyle changes and drugs, for example medicines for seizures, reflux, constipation, sleep problems, or attention and anxiety, along with hearing or vision aids, dental care, and, when needed, surgery for structural issues like undescended testes or skeletal differences. Regular check-ins with a coordinated team—pediatrics, neurology, genetics, cardiology, gastroenterology, and others—help adjust treatment over time, and genetic counseling can guide family planning and connect you with resources.
Non-drug treatment
Daily life with Coffin-Siris syndrome 1 often involves supporting development, communication, feeding, and learning at each stage of growth. Beyond prescriptions, supportive therapies can help children and adults build skills, stay healthy, and participate more fully at home and school. Plans are tailored to the person, with regular check-ins as needs change. When possible, starting early brings the best chance to strengthen abilities and prevent avoidable complications.
Services in infancy target early symptoms of Coffin-Siris syndrome 1, like weak muscle tone or feeding trouble. Therapists coach caregivers on home activities that build skills during everyday routines.
Guided exercises strengthen muscles and improve balance and coordination. This can help with sitting, standing, walking, and joint stability.
Practice with fine-motor tasks builds hand skills needed for play, dressing, and self-care. Therapists also adapt tools to make daily tasks easier.
Sessions focus on understanding words, expressing needs, and social communication. Therapists may also address oral-motor skills that affect speech clarity in Coffin-Siris syndrome 1.
Your genes may have an impact on how drugs work for you
Medicines used for Coffin–Siris syndrome 1 are few and mainly supportive, and how well they work—or what side effects appear—can vary with each person’s genetic makeup. Differences in genes that process drugs can change dosing needs and tolerability.
Pharmacological treatments
Medicines for Coffin-Siris syndrome 1 focus on easing day-to-day symptoms like seizures, reflux, constipation, sleep difficulties, and behavior concerns. Drugs that target symptoms directly are called symptomatic treatments. Choices depend on each person’s needs, age, and other health issues, and plans may change over time. Medicines do not change the genetic cause, but they can ease early symptoms of Coffin-Siris syndrome 1 such as reflux, seizures, or sleep problems.
Levetiracetam, lamotrigine, or valproate are commonly used to reduce seizure frequency. Doctors match the medicine to the seizure type and side-effect profile.
Proton pump inhibitors like omeprazole or lansoprazole can calm heartburn and protect the esophagus. Thickened feeds and positioning often work alongside medicine.
Polyethylene glycol (macrogol) or lactulose helps soften stools and ease bowel movements. Regular fluids and fiber can make these medicines work better.
Melatonin at night can help set a more predictable sleep schedule. If needed, low-dose clonidine may be used for settling to sleep or night wakings.
Genetic influences
Most cases of Coffin-Siris syndrome 1 trace back to a change in a single gene called ARID1B, which helps control how other genes turn on and off during early development. A change in a gene (mutation or variant) can sometimes affect health. The inheritance pattern of Coffin-Siris syndrome 1 is autosomal dominant, meaning one altered copy can cause the condition, but in most families the change arises “new” in the child rather than being passed down. If a parent does carry the ARID1B change, each pregnancy has a 50% chance of inheriting it; when parents test negative, the chance of it happening again is low—though not zero—because a small portion of egg or sperm cells can occasionally carry the change. The genetic causes of Coffin-Siris syndrome 1 include small changes within ARID1B or, less often, a missing stretch of DNA that includes this gene; both can disrupt its job and lead to the condition’s features. Because features can vary widely, even within a family, confirming the ARID1B change with genetic testing can clarify recurrence risk and help guide planning for care.
Is Coffin-siris syndrome 1 genetic?
Genetics are central to Coffin-Siris syndrome 1. Most cases result from a single harmful change in the ARID1B gene, often occurring for the first time in a child. Rarely, it can be inherited, and genetic testing confirms the diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
In Coffin-Siris syndrome 1, care is tailored to symptoms, and medicines are chosen for needs like seizures, behavior, feeding, or infections. The gene change that causes Coffin-Siris syndrome 1 doesn’t usually change how the body clears medicines, but your other genes can, which is the focus of pharmacogenetics and helps explain differences in drug response in Coffin-Siris syndrome 1. Genetic testing can sometimes identify how your body processes certain seizure medicines or ADHD treatments, which may guide dosing and reduce side effects. For example, some people break down drugs much more slowly or quickly, so a standard dose of clobazam, phenytoin, or atomoxetine may be too strong or too weak. In some ancestries, a specific immune-system marker can raise the risk of serious skin reactions with carbamazepine or similar seizure medicines, so doctors may screen before starting them. During anesthesia or sedation, plans are usually tailored more to airway and muscle tone than to drug–gene results, but sharing any past medication reactions helps your team plan safely.
Interactions with other conditions
People living with Coffin-Siris syndrome 1 (CSS1) often have other diagnoses alongside it, such as autism spectrum disorder, attention differences, or epilepsy; doctors call it a “comorbidity” when two conditions occur together. Early symptoms of Coffin-Siris syndrome 1 like feeding trouble and low muscle tone can lead to reflux or aspiration, which may make chest infections more frequent or harder to shake. If congenital heart differences are present, any respiratory illness can feel tougher, and recovery may take longer. Seizures may flare during fevers or infections, and some anti-seizure medicines can increase constipation or sleepiness, which are already common challenges in CSS1. Recurrent ear infections and hearing loss can compound speech and language delays, while vision problems can further affect learning and mobility. Curvature of the spine can reduce lung capacity as children grow, so a bad cold or pneumonia may hit harder than expected.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who were smaller than expected, developed skills later than their peers, and had distinctive facial features that seemed to “run in the family.” Community stories often described the condition without a name, noting the way a child’s smile, short fifth fingers, or tiny toenails matched an older relative’s. Caregivers saved photos and letters, comparing milestones and sharing practical tips long before there was a unifying diagnosis.
First described in the medical literature as a cluster of features seen in several unrelated children, Coffin-Siris syndrome 1 began as a pattern recognized by attentive clinicians. Early reports focused on visible traits—coarse facial features, small nails on the pinky fingers and little toes, feeding challenges—because genetic tools were limited. Doctors drew careful pictures from symptoms and family histories, but the edges of that picture were blurry, and many people living with Coffin-Siris syndrome 1 were likely missed or labeled with other conditions.
Over time, descriptions became more consistent as specialists compared cases across hospitals and countries. As medical science evolved, teams noticed that some children shared developmental differences and a familiar facial appearance, even when their symptoms varied. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Advances in genetics changed the story. When DNA testing became more widely available, researchers connected these clinical patterns to changes in a gene that helps regulate how other genes turn on and off—a bit like a dimmer switch that sets the brightness for many biological processes. Identifying this specific gene change clarified that Coffin-Siris syndrome 1 is one part of a broader family of related conditions, helping explain why features can range from mild to more noticeable.
From early theories to modern research, the story of Coffin-Siris syndrome 1 shows how naming a condition can open doors to better support. Genetic confirmation allowed doctors to move beyond look-alike diagnoses, counsel families about recurrence risk, and tailor care plans. It also highlighted adults who had lived for years without a clear answer and children whose early symptoms of Coffin-Siris syndrome 1 were subtle.
In recent decades, knowledge has built on a long tradition of observation. Families, clinicians, and researchers now share data through registries and international collaborations, refining what is known about growth, learning, and health needs over a lifetime. Understanding the history of Coffin-Siris syndrome 1 helps explain why guidance today emphasizes both the common threads and the wide range of individual experiences.